Table 1. Proteins identified in COPD cohort Nasosorption FX-i samples

Excel file with tabs containing proteins identified across COPD and no COPD Nasosorption FX-i samples and proteins unique to COPD and no COPD samples described in Chapter 5 of the thesis entitled: "The Nasal Proteome as a Source of Biomarkers for SARS-CoV-2 and Lung Cancer".

Nasal mucus from Nasosorption FX-i devices from patients with and without COPD was eluted and processed for mass spectrometry analysis using S-Trap. Samples were analysed in a data-dependent manner and subsequently analysed using Proteome Discoverer software.

包含跨慢性阻塞性肺疾病（COPD）和无COPD的Nasosorption FX-i样本中鉴定出的蛋白质，以及在第5章中描述的仅限于COPD和无COPD样本的独特蛋白质的Excel文件，该章节标题为《鼻部蛋白质组作为SARS-CoV-2和肺癌生物标志物来源的研究》。来自患有和未患有COPD的患者的Nasosorption FX-i设备中的鼻粘液经过洗脱和处理，使用S-Trap进行质谱分析。样本以数据依赖的方式进行分析，随后使用蛋白质组发现者软件进行进一步分析。